The New Eugenics
By Jesse Reynolds,
Z Magazine
| 10. 31. 2002
As this article is being written, delegates from nearly every country are meeting at the United Nations to take the next steps towards an international convention banning human reproductive cloning. Human cloning is the latest, and loudest, in a series of new technologies of human reproductive and genetic manipulation that have – and will – elicit controversy and division in civil society. Additionally, enormous payments to egg “donors” with specific characteristics have been in college newspapers for several years (see “Assisted Reproductive Technologies,” July/August 2002, Z Magazine). Recently, the use of pre-implantation genetic diagnosis, in which embryos are screened for certain genetic characteristics before implantation via in vitro fertilization (IVF), for gender selection or non-disease traits has garnered attention. Soon, we can expect to see public debate over inheritable human genetic engineering, the technology with the greatest potential for social and biological impacts.
Human reproductive cloning is neither far-off science fiction nor banned taboo. The technology is imminent, and several rogue scientists are working to create cloned children. Although more than thirty countries have already passed laws prohibiting reproductive cloning...
Related Articles
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...